Organicell Regenerative Medicine, Inc.

OCELOTCHealthcare

$2.74

$-0.01(-0.27%)

Market Cap$19974944

P/E Ratio—

52W High$4.8

52W Low$0.896

Avg Volume2K

Open$2.65

Beta1.36

Insider Trades Ownership Employees

Organicell Regenerative Medicine, Inc.（OCEL）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · OCEL · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

4.00

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 80%仅显示有效交易 · 排除RSU归属20% Sell ↓

Organicell Regenerative Medicine, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

OCEL 季度内部人买卖趋势

OCEL 内幕交易卖出 · OCEL 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

219.0M109.5M0

2021 Q1

2021 Q2

2021 Q4

2022 Q3

2022 Q4

2023 Q2

2023 Q3

2023 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

近期内幕交易记录

OCEL 高管卖出股份 · OCEL 董事内幕交易 · SEC Form 4申报

显示最近 69 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Dec 19, 2023	Leider Harry L. CEO · Director	Sale	5,248	$1.31	$7K	0	Form 4
Jul 7, 2023	Skycrest Holdings, LLC 10 percent owner	Purchase	320,710	$0.01	$3K	51,720,710	Form 4
Jun 29, 2023	Skycrest Holdings, LLC 10 percent owner	Purchase	200,000	$0.01	$2K	51,400,000	Form 4
Jun 28, 2023	Skycrest Holdings, LLC 10 percent owner	Purchase	400,000	$0.01	$4K	51,200,000	Form 4
Jun 28, 2023	Leider Harry L. CEO · Director	Purchase	549,450	$0.10	$54K	549,450	Form 4
Jun 26, 2023	Skycrest Holdings, LLC 10 percent owner	Purchase	800,000	$0.01	$7K	50,800,000	Form 4
Oct 29, 2021	Mitrani Albert CEO · Director	Other	15,000,000	—	—	166,790,190	Form 4
Oct 29, 2021	Mitrani Albert CEO · Director	Other	15,000,000	—	—	151,790,190	Form 4
Oct 29, 2021	MITRANI MARIA INES Chief Science Officer	Other	15,000,000	—	—	116,707,890	Form 4
Oct 29, 2021	MITRANI MARIA INES Chief Science Officer	Other	15,000,000	—	—	101,707,890	Form 4
Oct 29, 2021	Shapiro George Craig Chief Medical Officer · Director	Other	5,000,000	—	—	80,604,187	Form 4
Oct 29, 2021	Shapiro George Craig Chief Medical Officer · Director	Other	5,000,000	—	—	75,604,187	Form 4
Oct 29, 2021	BOTHWELL IAN T CFO · Director	Other	15,000,000	—	—	148,018,726	Form 4
Oct 29, 2021	BOTHWELL IAN T CFO · Director	Other	15,000,000	—	—	133,018,726	Form 4
Jun 17, 2021	Shapiro George Craig Chief Medical Officer · Director	Sale	9,955	$0.14	$1K	80,604,187	Form 4
Jun 17, 2021	MITRANI MARIA INES Chief Science Officer	Sale	5,228	$0.14	$732	116,752,662	Form 4
Jun 17, 2021	MITRANI MARIA INES Chief Science Officer	Sale	44,772	$0.14	$6K	116,707,890	Form 4
Jun 17, 2021	BOTHWELL IAN T CFO · Director	Sale	50,000	$0.14	$7K	148,018,726	Form 4
Jun 17, 2021	Mitrani Albert President · Director	Sale	50,000	$0.14	$7K	166,790,190	Form 4
Jun 14, 2021	Shapiro George Craig Chief Medical Officer · Director	Sale	32,000	$0.14	$4K	80,725,596	Form 4
Jun 15, 2021	Shapiro George Craig Chief Medical Officer · Director	Sale	50,000	$0.16	$8K	80,675,596	Form 4
Jun 16, 2021	Shapiro George Craig Chief Medical Officer · Director	Sale	40,375	$0.15	$6K	80,635,221	Form 4
Jun 16, 2021	Shapiro George Craig Chief Medical Officer · Director	Sale	21,079	$0.15	$3K	80,614,142	Form 4
Jun 14, 2021	MITRANI MARIA INES Chief Science Officer	Sale	50,000	$0.14	$7K	116,857,890	Form 4
Jun 15, 2021	MITRANI MARIA INES Chief Science Officer	Sale	50,000	$0.16	$8K	116,807,890	Form 4

Leider Harry L.

CEO · Director

Sale

日期

Dec 19

股数

5,248

均价

$1.31

总金额

$7K

View Form 4 on SEC.gov

Skycrest Holdings, LLC

10 percent owner

Purchase

日期

Jul 7

股数

320,710

均价

$0.01

总金额

$3K

View Form 4 on SEC.gov

Skycrest Holdings, LLC

10 percent owner

Purchase

日期

Jun 29

股数

200,000

均价

$0.01

总金额

$2K

View Form 4 on SEC.gov

Skycrest Holdings, LLC

10 percent owner

Purchase

日期

Jun 28

股数

400,000

均价

$0.01

总金额

$4K

View Form 4 on SEC.gov

Leider Harry L.

CEO · Director

Purchase

日期

Jun 28

股数

549,450

均价

$0.10

总金额

$54K

View Form 4 on SEC.gov

Skycrest Holdings, LLC

10 percent owner

Purchase

日期

Jun 26

股数

800,000

均价

$0.01

总金额

$7K

View Form 4 on SEC.gov

Mitrani Albert

CEO · Director

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

Mitrani Albert

CEO · Director

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Other

日期

Oct 29

股数

5,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Other

日期

Oct 29

股数

5,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

BOTHWELL IAN T

CFO · Director

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

BOTHWELL IAN T

CFO · Director

Other

日期

Oct 29

股数

15,000,000

均价

—

总金额

—

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Sale

日期

Jun 17

股数

9,955

均价

$0.14

总金额

$1K

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Sale

日期

Jun 17

股数

5,228

均价

$0.14

总金额

$732

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Sale

日期

Jun 17

股数

44,772

均价

$0.14

总金额

$6K

View Form 4 on SEC.gov

BOTHWELL IAN T

CFO · Director

Sale

日期

Jun 17

股数

50,000

均价

$0.14

总金额

$7K

View Form 4 on SEC.gov

Mitrani Albert

President · Director

Sale

日期

Jun 17

股数

50,000

均价

$0.14

总金额

$7K

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Sale

日期

Jun 14

股数

32,000

均价

$0.14

总金额

$4K

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Sale

日期

Jun 15

股数

50,000

均价

$0.16

总金额

$8K

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Sale

日期

Jun 16

股数

40,375

均价

$0.15

总金额

$6K

View Form 4 on SEC.gov

Shapiro George Craig

Chief Medical Officer · Director

Sale

日期

Jun 16

股数

21,079

均价

$0.15

总金额

$3K

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Sale

日期

Jun 14

股数

50,000

均价

$0.14

总金额

$7K

View Form 4 on SEC.gov

MITRANI MARIA INES

Chief Science Officer

Sale

日期

Jun 15

股数

50,000

均价

$0.16

总金额

$8K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 OCEL 内幕交易

OCEL 内幕交易

Organicell Regenerative Medicine, Inc.（OCEL）内幕交易数据来源于公司内部人（包括OCEL）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。OCEL内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Organicell Regenerative Medicine, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

OCEL 内幕交易 · 5个问题

Organicell Regenerative Medicine, Inc.（OCEL）的内部人包括高管和董事，如OCEL等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

OCEL 董事内幕交易OCEL 内部人名单Organicell Regenerative Medicine, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026